Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1475 of 1631 entries
View as:

An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States

Phase: N/A Priority: Normal
NCT ID: NCT06272942 Org: User:
Start: 01/31/24 End: 08/30/25 Due: 08/30/26

A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia

Phase: N/A Priority: Normal
NCT ID: NCT04899661 Org: User:
Start: 08/06/21 End: 09/30/27 Due: 09/30/28

A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05587296 Org: User:
Start: 10/14/22 End: 06/25/27 Due: 06/25/28

To Evaluate Clinical Outcome and Injection Compliance of Scilin

Phase: N/A Priority: Normal
NCT ID: NCT01588639 Org: User:
Start: 08/31/12 End: 01/31/14 Due: 01/31/15

A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT06149520 Org: User:
Start: 01/15/24 End: 12/26/25 Due: 12/26/26

A Study to Learn About the Occurrence of Disseminated Intravascular Coagulation in People With Sepsis and Further Worsening of Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT06986798 Org: User:
Start: 01/29/25 End: 04/07/26 Due: 04/07/27

Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine

Phase: N/A Priority: Normal
NCT ID: NCT01118273 Org: User:
Start: 01/31/08 End: 02/29/08 Due: 02/28/09

Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients

Phase: N/A Priority: Normal
NCT ID: NCT02606864 Org: User:
Start: 12/31/15 End: 08/31/16 Due: 08/31/17

Effect on Primary Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT00909857 Org: User:
Start: 04/30/09 End: 11/30/10 Due: 11/30/11

Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01117623 Org: User:
Start: 02/28/07 End: 11/30/13 Due: 11/30/14

Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.

Phase: N/A Priority: Normal
NCT ID: NCT04507061 Org: User:
Start: 09/01/20 End: 04/05/22 Due: 04/05/23

Human Photoallergy Test (824/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02962869 Org: User:
Start: 11/03/16 End: 12/31/16 Due: 12/31/17

BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT03427788 Org: User:
Start: 03/21/18 End: 02/11/19 Due: 02/11/20

Phase I Trial of BAY1251152 for Advanced Blood Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02745743 Org: User:
Start: 06/17/16 End: 08/03/18 Due: 08/03/19

First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01881217 Org: User:
Start: 06/28/13 End: 08/16/16 Due: 08/16/17

Risk Minimisation Study for Diane-35 and Its Generics

Phase: N/A Priority: Normal
NCT ID: NCT02410031 Org: User:
Start: 06/26/15 End: 03/04/16 Due: 03/04/17

Symptomatic Treatment of Common Cold Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01033526 Org: User:
Start: 10/31/05 End: 06/30/07 Due: 06/30/08

Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT01839630 Org: User:
Start: 05/30/13 End: 12/29/16 Due: 12/29/17

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT03098979 Org: User:
Start: 05/10/17 End: 06/20/18 Due: 06/20/19

Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01096030 Org: User:
Start: 07/31/10 End: 11/30/12 Due: 11/30/13

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00398905 Org: User:
Start: 01/31/04 End: 09/30/04 Due: 09/30/05

Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552

Phase: N/A Priority: Normal
NCT ID: NCT01110590 Org: User:
Start: 01/31/10 End: 05/31/10 Due: 05/31/11

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

Phase: N/A Priority: Normal
NCT ID: NCT03666273 Org: User:
Start: 09/12/18 End: 05/15/24 Due: 05/15/25

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Phase: N/A Priority: Normal
NCT ID: NCT02671097 Org: User:
Start: 02/29/16 End: 08/31/16 Due: 08/31/17

Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Phase: N/A Priority: Normal
NCT ID: NCT01105208 Org: User:
Start: 03/31/10 End: 03/31/10 Due: 03/31/11